Spécialités pharmaceutiques à base de déférasirox
Reference 730541-2026
Only published in French/Dutch
- Who is buying
- Healthcare Public Procurement (HeCaPP) Only published in French/Dutch
- Place
- Belgium
- The deadline
- Published value
- Unknown
- CPV
- 33600000
Spécialités pharmaceutiques à base de déférasirox
Only published in French/Dutch
Prepare and fill in my offer
Dictation drawn from the TED notice and the documents that were read, in order. Each step repeats the published text and where it was read. No field is added. aoex does not submit the offer.
Copy the dictation. Download the PDF. aoex does not submit the offer for you. Only published text is repeated here. The tender documents prevail.
Similar tenders still open
- Spécialités pharmaceutiques à base de rituximab IV
- Who is buying
- Healthcare Public Procurement (HeCaPP)
- The deadline
- Spécialité pharmaceutique à base d'immunoglobulines issues du plasma humain à administration IV
- Who is buying
- Healthcare Public Procurement (HeCaPP)
- The deadline
- Raamovereenkomst voor Luspatercept
- Who is buying
- AZ Sint-Jan Brugge AV
- The deadline
- Ayant pour objet la fourniture de Méthotrexate SC (ATC : L04AX03)
- Who is buying
- Centrale de Négociation pour les Achats Hospitaliers
- The deadline
- Pluri-attributaire relatif à la fourniture d’AFLIBERCEPT en seringue préremplie pour les besoins des pharmacies de Vivalia, agissant en Centrale d’achats
- Who is buying
- Vivalia
- The deadline
- Raamovereenkomst voor de aankoop van Aflibercept en Ranibizumab
- Who is buying
- Universitair Ziekenhuis Brussel
- The deadline
